jueves, 13 de febrero de 2025
Cabozantinib Improves PFS in Advanced Neuroendocrine Tumors After Prior Treatment Edited by Katie Lennon February 13, 2025
Cabozantinib Improves PFS in Advanced Neuroendocrine Tumors After Prior Treatment
Edited by Katie Lennon
https://www.medscape.com/viewarticle/cabozantinib-improves-pfs-advanced-neuroendocrine-tumors-2025a10003s3
February 13, 2025
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario